Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2022

Pharma News, 2022

FDA Grants Fast Track Designation to Abelacimab
FDA Grants Fast Track Designation to Abelacimab
The FDA granted Fast Track status to Anthos Therapeutics’ investigational monoclonal antibody, abelacimab, for treatment of patients with cancer-associated blood clots. ...
Horizon’s Krystexxa Approved for Treating Uncontrolled Gout
Horizon’s Krystexxa Approved for Treating Uncontrolled Gout
The FDA has approved Horizon Therapeutics’ supplemental Biologics License Application (sBLA) for its injectable drug, Krystexxa (pegloticase), coadministered with methotrexate for patients with u...
Genetically engineered pig hearts transplanted into dead people
Genetically engineered pig hearts transplanted into dead people
Researchers successfully transplanted genetically modified pig hearts into two recently deceased people connected to ventilators, the New York University team announced today. ...
AbbVie cuts Alzheimer’s alliance with Alector in half
AbbVie cuts Alzheimer’s alliance with Alector in half
AbbVie is pulling out of its collaboration with Alector on the development of Alzheimer’s disease candidate AL003, which aims to tackle the neurodegenerative disease by restoring reduced immune s...
Vertex to Acquire ViaCyte for $320 Million
Vertex to Acquire ViaCyte for $320 Million
Vertex Pharmaceuticals has entered into a $320 million agreement to acquire ViaCyte, a privately held biotechnology company focused on delivering novel stem cell-derived cell replacement therapies...
Chemical heals wounds twice as fast, could be antibiotic alternative
Chemical heals wounds twice as fast, could be antibiotic alternative

Israeli scientists say they have used a natural chemical to make pigs’ wounds heal twice as fast as they otherwise would.

World Health Organization warns COVID-19 is 'running freely' and global deaths are unacceptably high
World Health Organization warns COVID-19 is 'running freely' and global deaths are unacceptably high
The head of the World Health Organisaton (WHO) has urged governments across the world to deploy measures like masking and improved ventilation amid unacceptably high numbers of deaths. ...
FDA Grants Approval to Pfizer-BioNTech COVID-19 Vaccine for Children 12 to 15 Years Old
FDA Grants Approval to Pfizer-BioNTech COVID-19 Vaccine for Children 12 to 15 Years Old
The FDA has granted full approved to Pfizer-BioNTech’s COVID-19 vaccine for children aged 12 to 15 years old, making it the only FDA-approved vaccine for that age group. ...
Sobi and ADC Therapeutics Ink Licensing Deal Worth Up to $435 Million
Sobi and ADC Therapeutics Ink Licensing Deal Worth Up to $435 Million
Sobi has inked a licensing agreement with ADC Therapeutics for the company’s cancer drug, Zynlonta (loncastuximab tesirine-lpyl), for treatment of all hematologic and solid tumor indications out...
FDA Declines NRx’s EUA for Zyesami a Second Time
FDA Declines NRx’s EUA for Zyesami a Second Time
The FDA has declined NRx Pharmaceuticals’ Emergency Use Authorization (EUA) application a second time for Zyesami (aviptadil), this time for a subgroup of COVID-19 patients at immediate risk of ...
Doctors using AI catch breast cancer more often than either does alone
Doctors using AI catch breast cancer more often than either does alone

Radiologists assisted by an AI screen for breast cancer more successfully than they do when they work alone, according to new research. 

FDA approves sBLA for Krystexxa
FDA approves sBLA for Krystexxa
Horizon Therapeutics (Nasdaq: HZNP) has announced that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) expanding the labeling to include...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand